-
FDA Approves Generic Version of AstraZenecas Prilosec; Pegasys
Approved To Treat Hepatitis C; HRT Reduces Alzheimers Risk, Study
Says; Heparin Plus Alteplase More Effective; Digoxin Effects Differ By
Sex; McClellan Named FDA Commissioner; FDA Actions
-
An excellent update on rabies was provided by Charles E. Rupprecht, the Rabies Section Chief of the CDC, during the Symposium, Control of Zoonoses: A Veterinary Perspective at the recent 51st annual ASTMH meeting in Denver, Colo.
-
New data and consensus discussions provide updated guidance about the use of hepatitis A vaccine for young children, in US residents, and in individuals who are traveling very soon after their pretravel consultations.
-
Although Japanese encephalitis rarely occurs in travelers, certain groups and subsets of individuals have a risk of infection that can reach 1 in 5000 travelers per week. It is crucial to recognize those with increased risk, and to seriously consider immunizing them in order to prevent the potentially devastating sequelae of Japanese encephalitis.
-
Two recent publications cover common issues pertinent to travelers. There is a new way to expedite the diagnosis and treatment of myiasis, which is reviewed here. Included is also a synopsis of an illustrative article to make available to those who give advice to travelers regarding health care abroad.
-
Review of Efficacy of Ginkgo; Celebrex OK for Asthma Patients; Losartan Not Superior to Captopril; Alfa-Interferon Could Help Fight West Nile; FDA Actions
-
Careful evaluation of epidemiologic data from recent African outbreaks of meningococcal disease suggests that significant risks now extend beyond the sub-Saharan belt through the Rift Valley and Great Lakes regions into Mozambique, then into Namibia and Angola.
-
This invited article reviewing schistosomiasis in travelers describes the pertinent features of this disease as it presents in the nonimmune tourist.
-
A 56-year-old man, originally from india and with a history of hypertension, had developed bilateral red, swollen ankles while on a recent trip to Bangalore. Five days later, the patient developed severe fever and shaking chills that resolved within 48 hrs.
-
Drug Labels A Prescription for Misunderstanding?; Osteonecrosis of the Jaw New Side-Effect to Bisphosphate Use; Beta-Blockers and Depression Unlinked?; FDA Actions
